Affordable Access

Multimodal Imaging Probe Development for Pancreatic beta Cells: From Fluorescence to PET

  • Kang, Nam-Young
  • Lee, Jung Yeol
  • Lee, Sang Hee
  • Song, In Ho
  • Hwang, Yong Hwa
  • Kim, Min Jun
  • Phue, Wut Hmone
  • Agrawalla, Bikram Keshari
  • Wan, Si Yan Diana
  • Lalic, Janise
  • Park, Sung-Jin
  • Kim, Jong-Jin
  • Kwon, Haw-Young
  • Im, So Hee
  • Bae, Myung Ae
  • Ahn, Jin Hee
  • Lim, Chang Siang
  • Teo, Adrian Kee Keong
  • Park, Sunyou
  • Kim, Sang Eun
  • And 3 more
Publication Date
Feb 01, 2020
[email protected]
External links


Pancreatic beta cells are responsible for insulin secretion and are important for glucose regulation in a healthy body and diabetic disease patient without prelabeling of islets. While the conventional biomarkers for diabetes have been glucose and insulin concentrations in the blood, the direct determination of the pancreatic beta cell mass would provide critical information for the disease status and progression. By combining fluorination and diversity-oriented fluorescence library strategy, we have developed a multimodal pancreatic beta cell probe PiF for both fluorescence and for PET (positron emission tomography). By simple tail vein injection, PiF stains pancreatic beta cells specifically and allows intraoperative fluorescent imaging of pancreatic islets. PiF-injected pancreatic tissue even facilitated an antibody-free islet analysis within 2 h, dramatically accelerating the day-long histological procedure without any fixing and dehydration step. Not only islets in the pancreas but also the low background of PiF in the liver allowed us to monitor the intraportal transplanted islets, which is the first in vivo visualization of transplanted human islets without a prelabeling of the islets. Finally, we could replace the built-in fluorine atom in PiF with radioactive 18F and successfully demonstrate in situ PET imaging for pancreatic islets. / 1 / N

Report this publication


Seen <100 times